In the current study, HLA-I ligands and co-associations of KIR-HLA were examined for a limited number of subjects; also an inadequate number of patients with different lung cancer subtypes hindered the evaluation of KIRs and HLA-I genes impact within subgroups. Here, KIR3DL1 is linked to lung cancer.